Instrument Inactif

Autres langues Insys Therapeutics Nasdaq

Actions

Autres langues

27/11/20	Special Fraud Alert: Speaker Programs – If It's Too Good To Be True, It Probably Is
31/03/20	INSYS Therapeutics, Inc.'s Equity Buyback announced on November 5, 2015, has expired.
18/02/20	INSYS Therapeutics, Inc. Went Out of Business
11/02/20	INSYS THERAPEUTICS, INC. : Other Events (form 8-K)
10/02/20	INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
06/02/20	Bankruptcy Judge Changed for INSYS Therapeutics, Inc.
05/02/20	INSYS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
22/01/20	Second Motion for Exclusivity Period Extension Approved For INSYS Therapeutics, Inc.
17/01/20	INSYS THERAPEUTICS, INC. : Regulation FD Disclosure (form 8-K)
16/01/20	Modified Second Amended Liquidation Plan Approved for INSYS Therapeutics, Inc.
14/01/20	INSYS Therapeutics : Ex-pharma exec sentenced to nearly 3 years in bribery scheme
12/01/20	INSYS Therapeutics : Ex-drug company execs face reckoning in opioid bribery case
10/01/20	INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
06/01/20	INSYS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
26/12/19	INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
19/12/19	Renaissance Lakewood, LLC completed the acquisition of certain assets of INSYS Therapeutics, Inc. (OTCPK:INSY.Q).
16/12/19	Motion for Asset Sale Approved for INSYS Therapeutics, Inc.
04/12/19	Second Amended Disclosure Statement Approved for INSYS Therapeutics, Inc.
03/12/19	INSYS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Changes in Registrant's Certifying Accountant, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
03/12/19	Renaissance Lakewood, LLC entered into an asset purchase agreement to acquire certain assets of INSYS Therapeutics, Inc. (OTCPK:INSY.Q) for $0.28 million.
29/11/19	Second Amended Liquidation Plan And Disclosure Statement Filed by INSYS Therapeutics, Inc.
20/11/19	INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
14/11/19	First Amended Liquidation Plan Filed by INSYS Therapeutics, Inc.
04/11/19	First Motion for Exclusivity Period Extension Approved For INSYS Therapeutics, Inc.
31/10/19	Chilion Group Holdings US, Inc. completed the acquisition of Assets from INSYS Therapeutics, Inc. (OTCPK:INSY.Q) for $12.3 million.